NCT00246194View on ClinicalTrials.gov

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

CompletedOBSERVATIONAL

Enrollment

532

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Schizophrenia

Interventions

DRUG

risperidone (RISPERDAL CONSTA)

Long-acting injectable of risperidone given as per the prescription from the prescribing physician.

Trial Locations (1)

Unknown

Rockville

All Listed Sponsors

lead

Janssen, LP

INDUSTRY

NCT00246194 - Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) | Biotech Hunter | Biotech Hunter